Mahmoud A.Al-Sha'er - Personal Information

Zarqa university

لا يوجد صورة

Mahmoud A.Al-Sha'er

Pharmacy

Staff Information

Academic Rank

Full Professor

Minor

الكيمياء الطبية وتصميم الادوية واكتشافها

Office No

204 د

Phone

1409

Email

a.mahmoud@zu.edu.jo

CV

View File

Qualifications

Bachelor

BSc Phamacy
Date : 1998.02.08

Master

MSc pharmaceutical sciences
Date : 2000.06.30

Ph.D.

PhD Drug Design and Molecular Modeling
Date : 2010.06.19

Papers
Conferences
Experiences

Research Name	Date Of Publication
Discovery of novel potent nuclear factor kappa-B inhibitors (IKK-β) via extensive ligand-based modeling and virtual screening,	2017/03
Mutasem Taha	2018/02
Evaluation of Novel Akt1 Inhibitors as Anticancer Agents using Virtual Co-crystallized Pharmacophore Generation	2015/10
Discovery of Check Point Kinase1 (Chk1) Inhibitors as Potential Anticancer Agents Using Ligand-Based Modelling and Virtual Screening	2015/10
Screening of miscellaneous Hsp90 inhibitors using virtual co-crystallized pharmacophore	2015/10
Docking and pharmacophore mapping of halogenated pyridinium derivatives on heat shock protein 90	2015/04
Docking and pharmacophore mapping of halogenEvaluation of antimicrobial activities of synthesiz ed pyridinium derivatives	2014/09
Discovery of nanomolar Phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modelling and virtual screening followed by in vitro analysis	2014/07
Could the cancer be a chronic immune disorder? Rather than a serious malignant disease	2014/05
Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis	2014/01
Design, Synthesis and Biological Evaluation of N4-Sulfonamido-Succinamic, Phthalamic, Acrylic and Benzoyl Acetic Acid Derivatives as Potential DPP IV Inhibitors	2014/01
Evaluation of miscellaneous heat shock protein (Hsp90) inhibitors using different methodologies	2013/09
Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors	2013/03
1-[2-Substituted ethyl]-2-methyl-5-nitroimidazole derivatives, synthesis and antibacterial activities	2013/01

Journal Name	Session Place

Activity Name	Date
Associated Researcher	2020/02/11